RT @JenniferSpicer4: Here's the link to the article https://t.co/8LaykMRhT5 And the link to our #EmoryID fellows' scholar blog w/ other li…
Here's the link to the article https://t.co/8LaykMRhT5 And the link to our #EmoryID fellows' scholar blog w/ other lit summaries by our ID fellows; plus visual abstracts & infographics created by our medical students. https://t.co/zwJZ7oCkyv
@auscandoc @neilrmciver @john_soles @KJFMartin @sheilawalker73 @barryjcooke1 @j_mcelroy There is a lot of misinformation out there, and even scientists are still stunned by so many crazy discoveries about this virus. To name a few, asymptomatic children, c
RT @amandalilja8: @DFisman @ASPphysician @GermHunterMD @CoburnBryan @janinemccready The ISTH interim guidelines have lots of interesting in…
RT @amandalilja8: @DFisman @ASPphysician @GermHunterMD @CoburnBryan @janinemccready The ISTH interim guidelines have lots of interesting in…
@DFisman @ASPphysician @GermHunterMD @CoburnBryan @janinemccready The ISTH interim guidelines have lots of interesting info about coagulopathy & COVID such as risk stratification, management of coagulopathy, the use of anti-coagulants https://t.co/XSq0
@isth have provided guidance (https://t.co/J9ePFZtoCl) which is provisional pending more understanding of the pathology, but provides important general guidance - all patients must have prophylactic LMWH unless bleeding/platelets under 25 and caution in se
@DamiaVII Creo que en hospital sí (anticoagulantes+ corticoides por vía iv), en USA existen protocolos públicos: https://t.co/ZnX3rUpEm9 https://t.co/r5Y4Z4ieBA https://t.co/I7jmfUtJfI
RT @CatchTheBaby: .@ISTH mgt of Coagulopathy in COVID‐19 https://t.co/YF4O2cl42Y @ISTH Webinar Thrombosis, Thromboprophylaxis & Coagulopat…
RT @KashPrime: Here's another paper that provides an algorithm for spotting and treating coagulopathies in Covid patients, and here is thei…
RT @PharmERToxGuy: Here's the link to the full, open-access ISTH article for #COVID19 coagulopathy guidance https://t.co/OVXtxDkadQ #FOAMed…
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 https://t.co/xxK25GI2fV
@miguelm_barrios lo que me parece interesante es la falta de un estudio en proceso, claro que es sabido que en CID vas a usar anticoagulantes pero no hay estudio especifico para covid 19 expandi todos creyeron las autopsias? https://t.co/gFTxmrM9lS https:
Sumamente interesante. https://t.co/kjhx2otsgX
RT @mtmdphd: @Dr_al_assadi @GermHunterMD @DeNovo_Fatima ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Ma…
RT @I_mitochondria: Hyperglycaemia=⬆️Clotting factors.Hyperinsulinemia=⬇️fibrinolysis (breakdown of clots). Sum=⬆️Thrombotic risk. MAJOR ca…
@Dr_al_assadi @GermHunterMD @DeNovo_Fatima ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal https://t.co/2N3pCxF6Es #2019nCoV #COVID19
RT @I_mitochondria: Hyperglycaemia=⬆️Clotting factors.Hyperinsulinemia=⬇️fibrinolysis (breakdown of clots). Sum=⬆️Thrombotic risk. MAJOR ca…
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
Hyperglycaemia=⬆️Clotting factors.Hyperinsulinemia=⬇️fibrinolysis (breakdown of clots). Sum=⬆️Thrombotic risk. MAJOR cause of Hyperglycemia=carbohydrate consumption. MAJOR cause of hyperinsulinemia=carbohydrate consumption https://t.co/73skyaQKDe
RT @Bloodman: Nice flowchart for COVID Coagulopathy
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
2. Pts with COVID19 tienen definitivamente hypercoagulabilidad. https://t.co/s5yX6IiqYs. En UCI los nosotros y la mayoría estamos AC con Lovenox si DDimer x6. https://t.co/Xq73dsAfca
RT @safh_info: 📔 Guía clínica sobre el manejo de la coagulopatía en COVID-19 💉 #guidelines #coagulopatia #COVIDー19 @isth https://t.co/qiboK…
Coagulation considerations wirh covid 19
@DrDHarmon We have also been using VTE prophylaxis dosing per recommendations from ISTH (https://t.co/sRNHS4O451) and ASH (https://t.co/ZMZBvAlx7P).
RT @Aiims1742: #COVID19 & clots https://t.co/NqQ80v8gHD Interim @isth guidelines (h/t @aakonc) https://t.co/o59BI3F4F7 Cc: @tmprowell
RT @Aiims1742: #COVID19 & clots https://t.co/NqQ80v8gHD Interim @isth guidelines (h/t @aakonc) https://t.co/o59BI3F4F7 Cc: @tmprowell
#COVID19 & clots https://t.co/NqQ80v8gHD Interim @isth guidelines (h/t @aakonc) https://t.co/o59BI3F4F7 Cc: @tmprowell
RT @srrezaie: ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19 https://t.co/n744WrADvO Developed a guidanc…
ISTH interim guidance on recognition and management of coagulopathy in COVID-19. https://t.co/I7evf1GJdC #FOAMed #Meded #MedTwitter #internalmedicine #cardiotwitter #mededbot #medschool #pulmonology #COVID19 #COVIDfoam https://t.co/TKMqanVk3g
RT @srrezaie: ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19 https://t.co/n744WrADvO Developed a guidanc…
RT @srrezaie: ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19 https://t.co/n744WrADvO Developed a guidanc…
RT @srrezaie: ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19 https://t.co/n744WrADvO Developed a guidanc…
RT @srrezaie: ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19 https://t.co/n744WrADvO Developed a guidanc…
RT @srrezaie: ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19 https://t.co/n744WrADvO Developed a guidanc…
RT @CatchTheBaby: @GermHunterMD I wonder if these derm signs are related to Thrombotic Microangiopathy and if LMWH could treat. Severe #CO…
RT @srrezaie: ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19 https://t.co/n744WrADvO Developed a guidanc…
RT @srrezaie: ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19 https://t.co/n744WrADvO Developed a guidanc…
RT @CatchTheBaby: @GermHunterMD I wonder if these derm signs are related to Thrombotic Microangiopathy and if LMWH could treat. Severe #CO…
RT @CatchTheBaby: .@ISTH mgt of Coagulopathy in COVID‐19 https://t.co/YF4O2cl42Y @ISTH Webinar Thrombosis, Thromboprophylaxis & Coagulopat…
RT @srrezaie: ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19 https://t.co/n744WrADvO Developed a guidanc…
RT @srrezaie: ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19 https://t.co/n744WrADvO Developed a guidanc…
RT @srrezaie: ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19 https://t.co/n744WrADvO Developed a guidanc…
RT @CatchTheBaby: .@ISTH mgt of Coagulopathy in COVID‐19 https://t.co/YF4O2cl42Y @ISTH Webinar Thrombosis, Thromboprophylaxis & Coagulopat…
RT @CatchTheBaby: @GermHunterMD I wonder if these derm signs are related to Thrombotic Microangiopathy and if LMWH could treat. Severe #CO…
RT @CatchTheBaby: .@ISTH mgt of Coagulopathy in COVID‐19 https://t.co/YF4O2cl42Y @ISTH Webinar Thrombosis, Thromboprophylaxis & Coagulopat…
RT @CatchTheBaby: @GermHunterMD I wonder if these derm signs are related to Thrombotic Microangiopathy and if LMWH could treat. Severe #CO…
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
RT @CatchTheBaby: .@ISTH mgt of Coagulopathy in COVID‐19 https://t.co/YF4O2cl42Y @ISTH Webinar Thrombosis, Thromboprophylaxis & Coagulopat…
RT @CatchTheBaby: @GermHunterMD I wonder if these derm signs are related to Thrombotic Microangiopathy and if LMWH could treat. Severe #CO…
RT @CatchTheBaby: .@ISTH mgt of Coagulopathy in COVID‐19 https://t.co/YF4O2cl42Y @ISTH Webinar Thrombosis, Thromboprophylaxis & Coagulopat…
RT @CatchTheBaby: .@ISTH mgt of Coagulopathy in COVID‐19 https://t.co/YF4O2cl42Y @ISTH Webinar Thrombosis, Thromboprophylaxis & Coagulopat…
RT @CatchTheBaby: .@ISTH mgt of Coagulopathy in COVID‐19 https://t.co/YF4O2cl42Y @ISTH Webinar Thrombosis, Thromboprophylaxis & Coagulopat…
RT @mtmdphd: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal http…
Anticoagulation in covid patients https://t.co/rJ6HshHpAl
@GermHunterMD I wonder if these derm signs are related to Thrombotic Microangiopathy and if LMWH could treat. Severe #COVID19 infection assoc w/coagulopathy w/ features of both DIC and Thrombotic Microangiopathy. See info below from @isth cc:@bhwords @ma
RT @mtmdphd: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal http…
RT @safh_info: 📔 Guía clínica sobre el manejo de la coagulopatía en COVID-19 💉 #guidelines #coagulopatia #COVIDー19 @isth https://t.co/qiboK…
RT @mtmdphd: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal http…
RT @mtmdphd: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal http…
RT @mtmdphd: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal http…
RT @PharmacyToDose: Guidance from the ISTH on the management of coagulopathy in COVID-19 patients. https://t.co/6Plm2Khlkq #PharmICU #Twit…
RT @mtmdphd: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal http…
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
RT @mtmdphd: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal http…
RT @mtmdphd: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal http…
RT @mtmdphd: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal http…
RT @mtmdphd: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal http…
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
RT @EtonnantNon4456: @edgarmorinparis @Hemarina Oui il y a de nombreuses sur l'incidence vasculaire et spécifique du covid Coagulation, t…
Guidance from the ISTH on the management of coagulopathy in COVID-19 patients. https://t.co/6Plm2Khlkq #PharmICU #TwitteRX #COVID19 https://t.co/tEXWhKm9KI
RT @mtmdphd: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal http…
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal https://t.co/2N3pCxF6Es #2019nCoV #COVID19
RT @ATRIUMRx: Interesting take, but the dosing is entirely arbitrary and perhaps(?) too aggressive (particularly in those with renal dysfun…
Interesting take, but the dosing is entirely arbitrary and perhaps(?) too aggressive (particularly in those with renal dysfunction). @isth offers more even keel recommendations (see link). https://t.co/74lnUp7yIL
RT @KashPrime: Here's another paper that provides an algorithm for spotting and treating coagulopathies in Covid patients, and here is thei…
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
RT @Fer_martinmoro: 💻 Webinar @SETH__Oficial: https://t.co/mHtNJtVbcF 🎯 Recomendaciones @SETH__Oficial y @sehh_es: https://t.co/b6vClz6m…
RT @wabipconnect: Coagulopathy management for COVID-19. Open access @ https://t.co/2xkGkR9w4T
RT @PharmERToxGuy: Here's the link to the full, open-access ISTH article for #COVID19 coagulopathy guidance https://t.co/OVXtxDkadQ #FOAMed…
RT @mtmdphd: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 [Mar 25, 2020] Thachil et al. @JTHjournal http…
RT @KashPrime: Here's another paper that provides an algorithm for spotting and treating coagulopathies in Covid patients, and here is thei…